news
Corona
Pfizer examines: a third vaccine dose to deal with corona mutations
The pharmaceutical company has begun trials of a booster dose that will increase the antibody production in vaccinated people 10 to 20 times. Alongside this, it is developing an improved version of the vaccine, which can protect against the South African mutation
Tags
Corona virus
Vaccine for corona
Pfizer
News agencies
Thursday, 25 February 2021, 16:55
Share on Facebook
Share on WhatsApp
Share on general
Share on general
Share on Twitter
Share on Email
0 comments
Contrary to instructions: young people celebrate at a Purim party in Tel ...
The Constitution Committee approved the renewal of the isolation in hotels until ...
Biden: Ready to return to negotiations with Iran, must also be addressed ...
Netanyahu: intends to approve the night curfew from Thursday to Saturday ...
Volunteers clean tar from a beach in Hof Hasharon National Park
The Knesset approved: Details of non-vaccinated citizens will be transferred ...
Blue and white chairman Bnei Gantz at the Walla! NEWS studio in an interview ...
Netanyahu: We want to finish vaccinating vigorously and reach a full opening ...
Police filed a prosecutor's statement against Amir Raz, the suspect in the murder ...
Netanyahu refers to the environmental disaster of coastal pollution ...
In the video: Netanyahu promises that there will be no shortage of vaccines after talking to Pfizer CEO (Edit: Assaf Drori)
Pharmaceutical company Pfizer announced today (Thursday) that it has begun trials of a third vaccine against Corona, aimed at protecting against the new mutations.
The company also approached regulators to launch trials on an improved vaccine designed to deal with the South African strain, as part of the same study.
"We believe that the third dose will increase the antibody production in the vaccinated people 10-20 times," said the company's CEO Albert Burla.
Share on Facebook
Share on WhatsApp
Share on general
Share on general
Share on Twitter
Share on Email
0 comments
